US announces more ranitidine recalls due to possible cancer risk - News Summed Up

US announces more ranitidine recalls due to possible cancer risk


The FDA said that Denton Pharma Inc had recalled several batches of unexpired ranitidine tablets due to the possible presence of N-Nitrosodimethylamine NDMA, NBC reported on Friday. Appco Pharma also recalled batches of ranitidine because of the potential presence of NDMA. The recalled lots have an expiration date of April or May 2021. None of the recalled lots has been associated with any injuries or adverse events, according to the NBC. FDA testing of recalled ranitidine detected NDMA levels similar to the levels found in grilled and smoked meats, the NBC said.


Source: bd News24 January 11, 2020 14:03 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */